PCI’s Jeremy Osborne shares expertise on early clinical trials

The Manager of Project Management will talk at Clinical Trial Supply New England Conference 2019, giving advice on a fast and flexible entrance into the process

Jeremy Osborne will give a talk at Clinical Trial Supply New England Conference 2019

Biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) will share its specialist clinical trials expertise at the upcoming Clinical Trial Supply New England Conference 2019. The event will take place at the Westin Boston Waterfront, Boston, MA, on 26-27 March.

PCI’s Jeremy Osborne will take to the stage on Tuesday, March 26 at 9am EST, with his presentation ‘Accelerating into Early Clinical Trials with Speed and Flexibility’.

The Manager of Project Management at the US company will discuss how to create solutions to optimise limited drug supplies for clinical trials and the advantages of using Just-in-Time packaging for early phase studies. In addition, he will discuss how to utilise phase-specific processes to accelerate through Phase I and II, along with how to develop strategic choices to maximise flexibility in clinical supply strategies.

Osborne said: “Ensuring that projects are managed efficiently, cost-effectively and on time are crucial to the services customers expect and what we strive to deliver at PCI. We have a number of effective and reliable strategies in place to meet this demand and I am delighted to be able to share our wealth of knowledge with the New England region.”

PCI recently hosted events highlighting the advantages of executing early phase clinical studies. With considerable economic advantages paired with a favourable regulatory environment, broad access to diverse patient populations and well-established infrastructure, pharmaceutical and biotech companies are discovering many advantages to executing studies in the region, including speed to early phase studies.

Companies